Your browser doesn't support javascript.
loading
Incompatible intravenous drug combinations and respective physician and nurse knowledge: a study in routine paediatric intensive care.
Neininger, Martina P; Buchholz, Patricia; Frontini, Roberto; Kiess, Wieland; Siekmeyer, Werner; Bertsche, Astrid; Siekmeyer, Manuaela; Bertsche, Thilo.
Afiliação
  • Neininger MP; Department of Clinical Pharmacy and Drug Safety Center, Leipzig University, Leipzig, Germany.
  • Buchholz P; Department of Clinical Pharmacy and Drug Safety Center, Leipzig University, Leipzig, Germany.
  • Frontini R; Pharmacy Department of the University Hospital Leipzig and Drug Safety Center, Leipzig University, Leipzig, Germany.
  • Kiess W; Department of Clinical Pharmacy and Drug Safety Center, Leipzig University, Leipzig, Germany.
  • Siekmeyer W; Pharmacy Department of the University Hospital Leipzig and Drug Safety Center, Leipzig University, Leipzig, Germany.
  • Bertsche A; Department of Women and Child Health, Hospital for Children and Adolescents and Center for Pediatric Research, Leipzig University, Leipzig, Germany.
  • Siekmeyer M; Department of Women and Child Health, Hospital for Children and Adolescents and Center for Pediatric Research, Leipzig University, Leipzig, Germany.
  • Bertsche T; Department of Women and Child Health, Hospital for Children and Adolescents and Center for Pediatric Research, Leipzig University, Leipzig, Germany.
Eur J Hosp Pharm ; 26(4): 214-217, 2019 Jul.
Article em En | MEDLINE | ID: mdl-31338170
OBJECTIVES: To identify incompatible intravenous drug combinations in routine paediatric intensive care and evaluate physician and nurse knowledge. METHODS: In a university paediatric intensive care unit, intravenous drug incompatibilities were analysed using a database and physician and nurse knowledge of incompatibilities was assessed using a questionnaire. RESULTS: We analysed 665 prescriptions in 87 patients. Incompatible drug administration was identified in 9 (10%) of the 87 patients with a median of 3 different incompatibilities per patient (Q25/Q75: 1/3). We found 26 incompatible combinations. The most frequently involved drugs were cefotaxime, pantoprazole and vancomycin. A median of 10 of the 15 drug combinations were correctly assessed as compatible or incompatible (Q25/Q75: 8/11). Pantoprazole had a low number (20%) of correct answers. CONCLUSIONS: One in 10 patients in paediatric intensive care was affected by drug incompatibility, with knowledge deficits seen in a third of assessed combinations. This indicates quality improvement strategies should be urgently implemented by pharmacists.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Eur J Hosp Pharm Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Eur J Hosp Pharm Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha